SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-088038
Filing Date
2022-08-09
Accepted
2022-08-09 17:23:10
Documents
1
Period of Report
2022-08-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222999-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222999-5_4seq1.xml 4 3096
  Complete submission text file 0001104659-22-088038.txt   4649
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD C/O OSMOTICA PHARMACEUTICALS PLC BRIDGEWATER NJ 08807
Business Address
Schaub James (Reporting) CIK: 0001752153 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 221149539